BBSRC Portfolio Analyser
Award details
Disulfide bridging protein conjugation
Reference
BB/D003636/1
Principal Investigator / Supervisor
Professor Stephen Brocchini
Co-Investigators /
Co-Supervisors
Professor Sunil Shaunak
,
Dr Graham Taylor
,
Professor Mire Zloh
Institution
University College London
Department
Pharmaceutics
Funding type
Research
Value (£)
280,932
Status
Completed
Type
Research Grant
Start date
01/01/2006
End date
31/12/2007
Duration
24 months
Abstract
This proposal seeks to unequivocally prove our hypothesis that we can exploit for PEGylation the chemical selectivity of the thiols in the natural disulfides that exist in therapeutically relevant proteins while retaining the biological function of the protein. We describe preliminary results that demonstrate that it is possible with an immunomodulating protein such as interferon to partially reduce one of its disulfide bonds to site-specifically covalently conjugate both thiols and effectively reanneal the disulfide. Similar preliminary results have been obtained for the Fab for the CD4 antibody.
Summary
Over the last 20 years, protein based medicines have been acquiring an increasingly important role in the treatment of serious medical diseases. They are now the fastest growing sector of new medicines. Their rapid clearance from the body led to them being linked to poly(ethylene glycol) (PEG) as a means by which to prolong the protein's circulation time in the body and reduce its toxicity. This approach has been very successful. However, these current PEG technologies are severely limited and are only available to patients in resource rich countries. There is therefore an urgent need for innovative and cost-effective biotechnology that makes PEGylated proteins more widely available for patients with infectious diseases in resource poor countries. We describe a novel biotechnology that solves this problem, and illustrate its application to IFN-a2 for treating Hepatitis C infection, and to an anti-CD4 antibody fragment that prevents the cell-to-cell transmission of HIV-1.
Committee
Closed Committee - Engineering & Biological Systems (EBS)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search